ArticleNature communications2016
Plexciton Dirac points and topological modes.
Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 88 citations in OpenAlex.
- Towards field-resolved visible microscopy of 2D materials.Nanophotonics (Berlin, Germany) · 2025Article
- Increasing the Stability of Deep Blue Phosphor-Sensitized OLEDs Using the Polariton-Enhanced Purcell Effect.Advanced materials (Deerfield Beach, Fla.) · 2025Article
- Molecular and solid-state topological polaritons induced by population imbalance.Nanophotonics (Berlin, Germany) · 2023Article
- Template-assisted self-assembly of achiral plasmonic nanoparticles into chiral structures.Chemical science · 2022Review
- Plexcitonic Quasi-Bound States in the Continuum.Small (Weinheim an der Bergstrasse, Germany) · 2021Article
- Room temperature exciton-polariton Bose-Einstein condensation in organic single-crystal microribbon cavities.Nature communications · 2021Article
- Liquid-crystal-based topological photonics.Proceedings of the National Academy of Sciences of the United States of America · 2021Article
- Exploiting chemistry and molecular systems for quantum information science.Nature reviews. Chemistry · 2020Review
- Controlling the nonadiabatic electron-transfer reaction rate through molecular-vibration polaritons in the ultrastrong coupling regime.Scientific reports · 2020Article
- Strong light-matter interactions: a new direction within chemistry.Chemical Society reviews · 2019Review
- Theory for polariton-assisted remote energy transfer.Chemical science · 2018Article
- Polariton chemistry: controlling molecular dynamics with optical cavities.Chemical science · 2018Review
- Manipulating type-I and type-II Dirac polaritons in cavity-embedded honeycomb metasurfaces.Nature communications · 2018Article
- Topological magnetoplasmon.Nature communications · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plexcitons are polaritonic modes that result from the strong coupling between excitons and plasmons. Here, we consider plexcitons emerging from the interaction of excitons in an organic molecular layer with surface plasmons in a metallic film. We predict the emergence of Dirac cones in the two-dimensional band-structure of plexcitons due to the inherent alignment of the excitonic transitions in the organic layer. An external magnetic field opens a gap between the Dirac cones if the plexciton system is interfaced with a magneto-optical layer. The resulting energy gap becomes populated with topologically protected one-way modes, which travel at the interface of this plexcitonic system. Our theoretical proposal suggests that plexcitons are a convenient and simple platform for the exploration of exotic phases of matter and for the control of energy flow at the nanoscale.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.